Skip to main content
Clinical Trials/NCT05890326
NCT05890326
Completed
Not Applicable

Pain Neuroscience Education and Motor Imagery-based Exercise Protocol in Fibromyalgia

Uskudar University1 site in 1 country50 target enrollmentNovember 20, 2022

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Fibromyalgia
Sponsor
Uskudar University
Enrollment
50
Locations
1
Primary Endpoint
Visual Analogue Scale (VAS)
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

The main aim of this study is to find out whether applying both pain neuroscience education (PNE) and motor imagery-based exercise protocol (MIEP) will primarily reduce the pain of fibromyalgia. These therapies could show an evidence of improvement in fibromyalgia patients. However, there are no studies evaluating their effectiveness in combination.

Secondary outcomes:

To assess motor imagery ability of PNE in fibromyalgia patients

To assess motor imagery ability of MIEP in fibromyalgia patients

To evaluate the motor imagery ability of PNE+MIEP combined in fibromyalgia patients

To evaluate pain beliefs of PNE in fibromyalgia patients

To assess the pain beliefs of MIEP in fibromyalgia patients

Combined PNE+MIEP to assess pain beliefs in fibromyalgia patients.

To assess fear of movement in fibromyalgia patients of PNE

To assess fear of movement in fibromyalgia patients of MIEP

Combined PNE+MIEP to assess fear of movement in patients with fibromyalgia

PNE to assess anxiety, depression, cognitive and mood in patients with fibromyalgia.

To assess anxiety, depression, cognitive and mood in patients with fibromyalgia MIEP

To evaluate anxiety, depression, cognitive and mood in patients with fibromyalgia together with PNE+MIEP

PNE to assess self-esteem and body awareness in fibromyalgia patients.

To assess self-esteem and body awareness in fibromyalgia patients of MIEP

Combined PNE+MIEP to assess self-esteem and body awareness in fibromyalgia patients.

Registry
clinicaltrials.gov
Start Date
November 20, 2022
End Date
May 2, 2023
Last Updated
2 years ago
Study Type
Interventional
Study Design
Crossover
Sex
All

Investigators

Sponsor
Uskudar University
Responsible Party
Principal Investigator
Principal Investigator

Mesut Karahan

Assoc. Prof.

Uskudar University

Eligibility Criteria

Inclusion Criteria

  • Experiencing widespread chronic pain for more than 12 months
  • Pain in at least 12 or more of 18 tender points with a pressure of 5 kg/cm2
  • 18 to 60 years old
  • Not using pharmacological therapeutics
  • Not having participated in any pain program.
  • Not having participated in any physical exercise programs in the last twelve

Exclusion Criteria

  • Pregnancy
  • Not being able to do a physical activity program
  • Currently receiving treatment with any alternative medical methods (eg.hyperbaric).
  • Cardiovascular, psychiatric, autoimmune, cancer, etc. children with secondary different disease
  • Other causes of chronic pain
  • Receiving any treatment support related to pain
  • Mental disability status

Outcomes

Primary Outcomes

Visual Analogue Scale (VAS)

Time Frame: 12 weeks

Using a ruler, the score is determined by measuring the distance (mm) on the 10-cm line between the "no pain" anchor and the patient's mark, providing a range of scores from 0-100. A higher score indicates greater pain intensity.

Secondary Outcomes

  • The Pain Catastrophizing Scale (PCS)(12 weeks)
  • The Pain Beliefs Questionnaire (PBQ)(12 weeks)
  • Rosenberg Self-esteem Scale(12 weeks)
  • Adapting the Scale of Cognitive Emotion Regulation Strategies(12 weeks)
  • The Motion Imagery Questionnaire-3 (HLFS-3)(12 weeks)
  • The Tampa Scale for Kinesiophobia (TSK)(12 weeks)
  • Hospital Anxiety and Depression Scale (HADS)(12 weeks)
  • The Body Awareness Questionnaire(12 weeks)

Study Sites (1)

Loading locations...

Similar Trials